Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Activin RIA

Activin RIA

Brief Information

Name:Activin receptor type-1
Target Synonym:ACTR-I,ACVR1,Activin A Receptor Type 1,Serine/Threonine-Protein Kinase Receptor R1,Activin A Receptor, Type I,ACVRLK2,SKR1,Activin A Receptor, Type II-Like Kinase 2,Hydroxyalkyl-Protein Kinase,Activin Receptor Type-1,EC 2.7.11.30,ACVR1A,ACTRI,EC:2.7.11.30,TSR-I,ALK2,TSRI,FOP,Activin Receptors, Type I,ALK-2,Activin receptor type I,TGF-B superfamily receptor type I,EC 2.7.11,Activin receptor-like kinase 2
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
ACA-H5254 Human Human Activin RIA Protein, Fc Tag (MALS verified)
ACA-H5254-structure
ACA-H5254-sds
ACRO Quality

Part of Bioactivity data

ACA-H5254-ELISA
Activin RIA MALS images

The purity of Human Activin RIA Protein, Fc Tag (Cat. No. ACA-H5254) is more than 85% and the molecular weight of this protein is around 70-90 kDa verified by SEC-MALS.

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Momelotinib Dihydrochloride CYT-387; GS-0387; GSK-3070785 Approved Gilead Sciences Inc, Cytopia Pty Ltd Ojjaara, Omjjara United States Primary Myelofibrosis; Anemia Glaxosmithkline Llc, Glaxosmithkline Plc 2023-09-15 Polycythemia Vera; Anemia; Neoplasms; Myeloproliferative Disorders; Pancreatic Intraductal Neoplasms; Primary Myelofibrosis; Carcinoma, Pancreatic Ductal; Splenomegaly; Thrombocythemia, Essential; Carcinoma, Non-Small-Cell Lung Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
BLU-782 BLU-782; IPN-60130 Phase 2 Clinical Blueprint Medicines Corp, Ipsen SA Myositis Ossificans Details
Zilurgisertib INCB-000928; INCB-00928 Phase 2 Clinical Incyte Corp Polycythemia Vera; Renal Insufficiency; Anemia; Myelodysplastic Syndromes; Ossification, Heterotopic; Multiple Myeloma; Primary Myelofibrosis; Myositis Ossificans; Thrombocythemia, Essential Details
KER-047 KER-047 Phase 1 Clinical National Center For Advancing Translational Sciences Anemia, Iron-Deficiency; Myositis Ossificans Details
Itacnosertib TP-0184 Phase 1 Clinical Tolero Pharmaceuticals Inc, Sumitomo Dainippon Solid tumours; Anemia Details
BCX-9250 BCX-9250 Phase 1 Clinical Biocryst Pharmaceuticals Inc Myositis Ossificans Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message